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Abstract
Background: Fibroblast foci (FF) are considered a relevant morphologic marker of idiopathic pulmonary fibrosis/usual
interstitial pneumonia (IPF/UIP), and are recognised as sites where fibrotic responses are initiated and/or perpetuated in
this severe disease. Despite their relevance, the cellular and molecular mechanisms responsible for the formation of FF
and their role in tissue remodelling are poorly defined. In previous studies we have provided evidence of abnormal
activation of the wnt-signaling-pathway in IPF/UIP that is centred on FF and the overlying epithelium. This important
morphogenetic pathway is able to trigger epithelial-mesenchymal-transition (EMT), a mechanism involved in
developmental and metastatic processes, which is also potentially involved in pulmonary fibrosis.
Methods: Since EMT is characterised by enhancement of migratory potential of cells, we investigated the molecular
profile of FF in 30 biopsies of IPF/UIP and a variety of control samples, focussing on the immunohistochemical expression
of three molecules involved in cell motility and invasiveness, namely laminin-5-γ2-chain, fascin, and heat-shock-protein-27.
Results: We provide evidence that in UIP these three molecules are abnormally expressed in discrete clusters of
bronchiolar basal cells precisely localised in FF. These cellular clusters expressed laminin-5-γ2-chain and heat-shock-
protein-27 at very high levels, forming characteristic three-layered lesions defined as "sandwich-foci" (SW-FF). Upon
quantitative analysis SW-FF were present in 28/30 UIP samples, representing more than 50% of recognisable FF in 21/30,
but were exceedingly rare in a wide variety of lung pathologies examined as controls. In UIP, SW-FF were often observed
in areas of microscopic honeycombing, and were also found at the interface between normal lung tissue and areas of
dense scarring.
Conclusion: These molecular abnormalities strongly suggest that SW-FF represent the leading edge of pulmonary
remodelling, where abnormal migration and re-epithelialisation take place, and that abnormal proliferation and migration
of bronchiolar basal cells have a major role in the remodelling process characterising IPF/UIP. Further investigations will
assess their possible use as reliable markers for better defining the UIP-pattern in difficult cases.
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Idiopathic pulmonary fibrosis (IPF) is the most common
and severe idiopathic interstitial pneumonia [1,2]. In
affected portions of the lung irreversible remodelling of
tissue architecture takes place, which is histopathologi-
cally described as "usual interstitial pneumonia". In recent
years evolving opinions regarding the pathogenesis of this
specific chronic fibrosing disease have arose and different
models have been proposed [3-6]. Recently, the "inflam-
matory theory" of IPF/UIP has been challenged on the
assumption that abnormal epithelial-mesenchymal inter-
actions and aberrant wound healing are in fact crucial
pathogenetic events [3,4]. Although this new scheme is
appealing, many points remain unresolved, including the
nature of "fibroblast-foci" (FF), as well as the molecular
mechanisms responsible for alveolar loss, honeycomb
modifications, abnormal fibrosis and severe tissue remod-
elling. In previous studies we provided evidence that the
wnt/β-catenin signalling pathway is abnormally activated
in IPF/UIP, acting on both the alveolar and bronchiolar
components [7-9]. The central role played by the wnt/β-
catenin pathway in lung embryogenesis and pathology is
further demonstrated by the complex functions exerted by
this pathway in regulating a variety of crucial mecha-
nisms, including cell proliferation, apoptosis, cell migra-
tion, and angiogenesis [10]. Accordingly, the wnt-
signalling pathway regulates branching morphogenesis in
the lung, and can produce severe modifications in the
developmental potential of embryonic lung differentia-
tion when aberrantly expressed [11]. Interestingly, the
wnt/β-catenin pathway is a central trigger of epithelial-
mesenchymal transition (EMT), an important process
occurring during critical phases of embryonic develop-
ment, tumour progression, and fibrotic tissue repair in
different organs including the lung [12-14]. This possibil-
ity is relevant since such a new scheme could completely
change the pathogenic scenario for IPF/UIP, a devastating
disease where new therapeutic options are necessary [15].
We hypothesise that uncontrolled activation of wnt-β-cat-
enin pathway can profoundly influence tissue remodel-
ling in IPF/UIP by triggering pronounced cell migration
and proliferation at sites of aberrant expression, thus
interfering with the physiologic molecular program deter-
mining correct tissue repair. A variety of molecules
involved in cell migration and invasion are in fact targets
of β-catenin transcriptional activation and/or regulation,
including matrylisin/MMP7 (a metalloproteinase with
multifunctional roles including the induction of epithe-
lial cell migration, apoptosis and metaplastic conversion)
[9,16,17], laminin-5 gamma-2 chain (LAM5γ2; a potent
migration-inducing factor expressed by epithelial cells in
healing tissues) [18], tenascin-C (a component of the
extracellular matrix expressed during development, neo-
plastic invasion and wound-healing) [19], and fascin (an
actin-binding protein involved in cell motility of epithe-
lial cells) [20,21]. Abnormal expression of matrilysin/
MMP7 has been demonstrated in UIP samples by both
analysis of gene expression and immunohistochemistry
[9,22], and tenascin has been found to be expressed at
high levels in fibroblast foci. However, only limited infor-
mation is available in UIP regarding the expression of
other molecules involved in cell migration, such as
LAM5γ2, fascin, and heat-shock protein-27 (HSP27), a
multifunctional stress-inducible molecule involved in the
modulation of actin microfilament dynamics and cell
migration [23-25].
In this study we have investigated the immunohistochem-
ical expression of LAM5γ2, fascin, and HSP27 in 30 cases
of UIP, and in a large variety of biopsies of other pulmo-
nary diseases used as controls.
Methods
All studies were carried out in compliance to the Helsinki
declaration and in accordance with Italian law, following
the ethical recommendations of the Institutions where
they were performed.
Study population
The study group consisted of 30 previously untreated
patients with clinical, radiographic, physiologic and bron-
choalveolar-lavage findings consistent with a diagnosis of
IPF. Histological examination of surgical lung biopsies
revealed all the major features of UIP according to recently
defined criteria [1,2]. Controls included normal lung tis-
sue (n = 5), and a variety of pathologic samples retrieved
from our files. Among these, a series of biopsies were
investigated showing UIP-like modifications: allergic
extrinsic alveolitis (n = 2), autoimmunity (n = 3), and
amiodarone toxicity (n = 1) also in addition to samples
showing extensive scarring with fibroblast foci (recurrent
pneumothorax, n = 5; carcinoma, n = 5; post-infection, n
= 2). Diffuse parenchymal lung diseases were also investi-
gated as controls, including non-specific interstitial pneu-
monia (NSIP, n = 5), cryptogenic organizing pneumonia
(COP, n = 10), acute interstitial pneumonia with diffuse
alveolar damage (AIP/DAD, n = 3), desquamative intersti-
tial pneumonia (DIP, n = 4), extrinsic allergic alveolitis
(EAA, n = 8), Langerhans' cell histiocytosis (LCH, n = 3),
acute eosinophilic pneumonia (AEP, n = 2), and airway-
centred interstitial fibrosis (ACIF, n = 3). All these cases
were defined according to the most recent diagnostic cri-
teria [1,2]. Diseases where severe airway remodelling is a
common feature were also included as controls (diffuse
panbronchiolitis, DPB, n = 1; constrictive bronchiolitis, n
= 2).Page 2 of 10
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Serial sections of UIP and control cases were immunos-
tained with monoclonal antibodies recognizing laminin-
5 gamma-2 chain (clone-4G1, DakoCytomation, Glos-
trup, Denmark), fascin (clone-55K-2, DakoCytomation),
and two different antibodies recognising heat-shock-pro-
tein-27 (clone-2B4, Novocastra, Newcastle, UK) and its
phosphorylated form (S82, a rabbit monoclonal antibody
recognising HSP27 phosphorylated on serine-82, Epitom-
ics-Inc, Burlingame, CA). Heat-induced antigen retrieval
was performed for 4G1, 55K-2 and S82 antibodies using a
microwave oven and citrate buffer 0.01 M pH7.0 (4G1),
and pH6.0 (55K-2 and S82) respectively, whereas no
treatment was used for 2B4 antibody. All samples were
processed using a sensitive avidin-streptavidin-peroxidase
technique (Biogenex San Ramon, CA) in an automated
staining system (GenoMx i6000, BioGenex). Sections
incubated without the primary antibody served as a nega-
tive control.
To better define the nature and level of differentiation of
the epithelial and mesenchymal lesions, we utilized anti-
bodies recognizing cytokeratin-8/18 as a pan-epithelial
marker, cytokeratin-5 (CK5) as a basal-cell marker, ∆N-
p63 isoform for bronchiolar basal cells, tenascin and α-
smooth-muscle actin (SMA) for fibroblast foci, CC10 for
clara-cells, and surfactant apoprotein-A (SPA) for pneu-
mocytes (see Table 1 for details). Double-marker analysis
was also performed in selected samples using either anti-
tenascin or anti-∆N-p63 antibodies, combined with 4G1
or 2B4 antibodies, in order to define the precise location
of LAM5γ2 and HSP27 immunoreactivity. These double-
marker methods have been previously described in detail
[7,26]. A similar technique was used for demonstrating
LAM5γ2 and tenascin.
Results
All the 30 samples of IPF were morphologically described
as usual interstitial pneumonia by the presence of typical
modifications. These included patchy interstitial fibrosis
alternating with normal or minimally affected parenchy-
mal tissue, and honeycombing. FF, morphologically
defined as circumscribed collections of loose organizing
connective tissue formed by spindle-shaped myofibrob-
lasts, was present in all samples, and quantified on serial
sections by immunostaining for αSMA and tenascin. The
number of FF was highly variable in different samples,
ranging from 1 to >10 per cm2. The epithelial cells overly-
ing FF were heterogeneous and appeared as either flat,
cuboidal, or ciliated.
Laminin-5 gamma-2 chain expression pattern in IPF/UIP 
samples and controls
A definite cell population exhibiting strong LAM5γ2
immunoreactivity was observed in IPF/UIP samples,
formed by positive cells localized within structures recog-
nised as fibroblast foci by morphology and tenascin
expression (Figs. 1, 2, 3). These cells had the immunophe-
notypic characteristics of bronchiolar basal cells (SPA-,
CK5+ and ∆Np63+ on serial sections and double-immu-
nostaining)(Figs. 2 and 3), formed linear sheets or small
aggregates of LAM5γ2+ cells overlying FF, and were char-
acteristically located between negative luminal sheets of
bronchiolar epithelial cells and negative myofibroblasts
(Figs. 1, 2, 3). Due to this characteristic pattern, these FF
were termed "sandwich-FF" (SW-FF). SW-FF were demon-
strated in 28/30 of UIP samples and the two negative cases
contained only rare FF. Quantitative analysis of SW-FF
showed that they were dependent on the area of tissue
available and the number of FF (range 0.5 – 10 × cm2 of
sample tissue). SW-FF accounted for more than 50% of FF
in 21/30 cases, were less than 50% of FF in 7/30 samples,
and were totally absent in the remaining 2/30 cases. The
epithelial cells overlying the non SW-FF exhibited the phe-
Table 1: Antibodies utilised in this study
Antigen Clone/Ab Reactivity Source
heat shock protein 27 clone 2B4 FF* in UIP Novocastra
Heat shock protein 27, 
phosphorylated on serine-82
S82, rabbit monoclonal FF in UIP Epitomics-Inc,
laminin-5γ-2 chain 4G1 FF in UIP DakoCytomation
fascin 55K-2 FF in UIP, vessels, myofibroblasts, dendritic cells DakoCytomation
α-smooth muscle actin 1A4 smooth muscle, myofibroblasts in FF DakoCytomation
CC10 urine protein 1 (rabbit polyclonal) Clara cells DakoCytomation
cytokeratin 8/18 clone 5D3 epithelial cells Biogenex
cytokeratin 5 clone XM26 bronchiolar basal cells Novocastra
∆N-p63 truncated isoform p40 (rabbit polyclonal) bronchiolar basal cells Oncogene Research
surfactant-apoprotein A (SP-A) clone PE-10 pneumocytes DakoCytomation
tenascin TN2 FF in UIP DakoCytomation
*FF: fibroblast fociPage 3 of 10
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LAM5γ2 and HSP27 expression in FF of UIP biopsiesFigure 1
LAM5γ2 and HSP27 expression in FF of UIP biopsies. Expression of LAM5γ2 (a, b, and c) and HSP27 (d, and e) in dif-
ferent cases of IPF/UIP. The immunoreactivity is similar for the two molecules, mainly restricted to basal cell sheets located 
between luminal bronchiolar cells and myofibroblast clusters of fibroblast foci (sandwich-FF).
FF
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Characterisation on serial sections of the cells expressing LAM5γ2, fascin and HSP27 in "sandwich-FF" of UIP biopsiesFigure 2
Characterisation on serial sections of the cells expressing LAM5γ2, fascin and HSP27 in "sandwich-FF" of UIP 
biopsies. (a) A fibroblast focus is shown by tenascin immunostaining in a UIP biopsy at the edge between dense scarring and 
scarcely involved lung (square frame). In (b) The same FF is analysed for HSP27 (brown) and tenascin (red) by double-marker 
immunostaining. The same lesion was studied using serial sections, showing that surfactant SPA is not expressed by overlying 
epithelial cells (c), but a cluster of basal cells expresses high level of fascin (d) and MMP7/matrylisin (e). In dmyofibroblasts 
show discrete immunoreactivity for fascin. In the f-g-hsequence a "sandwich-FF" is shown, immunostained on serial sections for 
fascin (f), LAM5γ2 (g), and keratin-5, a marker of bronchiolar basal cells (h).
a
b
c
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d e
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were also present in 5 end-stage cases where dense scar-
ring and honeycombing were prevalent, located within
the wall of microscopic honeycomb cysts. In all UIP sam-
ples LAM5γ2 expression was not observed in basal cells of
normal bronchioles, or in bronchioles exhibiting prolifer-
ative modifications (bronchiolisation, basal cell hyperpla-
sia, squamous metaplasia).
Focal LAM5γ2 cytoplasmic expression was observed in
scattered atypically enlarged type-II pneumocytes at sites
of tissue damage in all cases of IPF/UIP.
Control samples
LAM5γ2 expression was absent in all samples of normal
lung and was carefully evaluated in both the bronchiolar
and alveolar components in a variety of pulmonary disor-
ders. In particular, we focused on diseases characterised by
centrolobular involvement (hypersensitivity pneumoni-
tis, Langerhans' cell histiocytosis, air-centred interstitial
fibrosis/ACIF), by the occurrence of extensive bronchiolar
remodelling (diffuse panbronchiolitis and constrictive
bronchiolitis), or by the presence of epithelial damage
and organising connective tissue (AIP/DAD, AEP, OP/
COP, NSIP, autoimmune lung diseases, scarring lesions).
None of the bronchiolar cells in any of these pulmonary
biopsies expressed LAM5γ2 (Fig. 4), with the exception of
two cases characterised by extensive scarring (one pulmo-
nary carcinoma and one recurrent pneumothorax), where
scattered lesions resembling SW-FF could be focally
observed in enlarged bronchiolar structures.
In control cases focal LAM5γ2 immunoreactivity was
observed in abnormal/hypertrophic pneumocytes at sites
of alveolar damage (Fig. 4). Epithelial cells covering intra-
alveolar fibroblastic polyps (Masson's bodies) in OP/COP
samples variably expressed LAM5γ2 (Fig. 4), never exhib-
ited the sandwich pattern observed in UIP, and were char-
acterised by an alveolar pneumocyte immunophenotype
(SPA+, CK5-negative, ∆N-p63-negative).
HSP27 and phospho-HSP27 expression in IPF/UIP and 
controls
The immunoreactivity pattern observed with HSP27 and
phospho-HSP27 antibodies was practically identical to
that observed for LAM5γ2 expression (Figs. 1, 2, 3).
Accordingly, HSP27 was absent in normal control lung,
with focal expression at sites of pneumocyte regeneration
in pathologic samples. IPF/UIP foci exhibiting the sand-
wich pattern were demonstrated at the same frequency
and location as observed with LAM5γ2 on serial sections,
using both 2B4 and S82 antibodies.
Fascin expression pattern in IPF/UIP samples and controls
The epithelial basal cells overlying FF exhibited elevated
levels of fascin, with a distribution similar to that
observed with LAM5γ2 and HSP27 (Fig. 2). These fascin
expressing cells were clearly recognised as CK5+, ∆N-p63+
basal cells upon immunophenotypical analysis of serial
sections (Fig. 2). Fascin expression was more widespread
than LAM5γ2 and HSP27, and different mesenchymal cell
components expressed this protein, including blood ves-
sels and myofibroblasts (Fig. 2). For this reason the sand-
wich pattern could not be easily recognised using fascin
Characterisation of "sandwich-FF" by double-marker immu-nostaining in UIP biopsiesFigure 3
Characterisation of "sandwich-FF" by double-marker 
immunostaining in UIP biopsies. In (a) nuclear immuno-
reactivity of ∆N-p63 (brown-black), a well established 
marker of bronchiolar basal cells, clearly defines the nature 
of the cells expressing LAM5γ2 (cytoplasmic red immunore-
activity). In (b), another sandwich lesion immunostained by 
the double marker technique and showing strong expression 
of tenascin in the cluster of myofibroblasts is seen (red). The 
cluster of basal cells located between tenascin+ myofibrob-
lasts and negative luminal bronchiolar cells strongly 
expresses LAM5γ2 (arrow).
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LAM5γ2 expression in control samplesFigure 4
LAM5γ2 expression in control samples. LAM5γ2 expression is observed in a subset of regenerating epithelial cells in cryp-
togenic organising pneumonia (COP, a), and diffuse alveolar damage/acute interstitial pneumonia (AIP/DAD, b), but is com-
pletely absent in allergic extrinsic alveolitis (AEA, c) and desquamative interstitial pneumonia (DIP, d), used as controls. In this 
UIP-like case (systemic sclerosis LAM5γ2 immunoreactivity was restricted to pneumocytes overlying FF (e, arrow), but the 
"sandwich" pattern was not observed despite the high number of fibroblast foci, as shown by tenascin immunostaining on serial 
sections (f, arrows).
a b
c d
ff
FF
e
Respiratory Research 2006, 7:95 http://respiratory-research.com/content/7/1/95immunostaining. All types of epithelial cells including
bronchiolar and alveolar cells were negative for fascin in
control samples, with the exception of regenerating pneu-
mocytes in pulmonary diseases where alveolar damage
was observed (AIP/DAD, COP, EAA, etc.).
Co-expression of wnt-β-catenin target gene products
When analysed on serial sections, basal cells expressing the
three molecules (LAM5γ2, HSP27 and fascin) in fibroblast
foci of UIP samples also expressed nuclear β-catenin and
matrilysin, as previously described [9] (Fig. 2).
Discussion
The pathogenesis of idiopathic interstitial pneumonia is
poorly defined and remains the subject of intense debate
and research. Although high-throughput molecular anal-
ysis has been applied to UIP samples with some success
[22,27], the precise definition of molecular events occur-
ring at sites of disease activity will require direct in situ
analysis of lung biopsies.
In this paper we provide in situ evidence that the epithelial
component overlying fibroblast foci (FF) expresses a set of
molecules involved in inducing cell motility and invasive-
ness, including LAM5γ2, fascin and HSP27. The relevance
of our findings is related to the specific functions of the
investigated molecules, as well as the characteristic tissue
localisation of their abnormal expression. The morphol-
ogy and location of this cellular component is in fact par-
ticularly intriguing, since positive cells appeared as linear
clusters of bronchiolar basal cells within FF, wedged
between luminal epithelial cells and myofibroblasts. The
recognition of these negative-positive-negative three-layered
lesions (that we termed "sandwich" fibroblast-foci or SW-
FF) was particularly evident using LAM5γ2 and HSP27 as
markers (Figs. 1 and 2).
The trimeric protein laminin-5 (α3, β3, γ2-chain) is an
integral part of the basal lamina of stratified epithelia
where it plays a crucial role in the organization of the
basal stem-cell niche by providing epithelial-mesenchy-
mal connections by interacting with integrin α6β4 [28].
These interactions are critical for regulating cell migration,
an event required in different processes, such as wound
healing, embryogenesis and metastatic dissemination
[29]. The γ2 chain of laminin-5 (LAM5γ2) acts as a soluble
cell motility factor in a variety of conditions after its cleav-
age by metalloproteinases, and enhanced expression of
LAM5γ2 is considered one of the best marker of invasive-
ness in different carcinomas [30-33]. At the invasive front
of colorectal carcinoma the cytoplasmic accumulation of
LAM5γ2 in neoplastic cells is the result of synergistic acti-
vation of the LAMC2 gene by β-catenin, TGFβ1, and hepa-
tocyte-growth factor (HGF), molecules that all have been
variably involved in the pathogenesis of IPF/UIP [9,18,34-
36]. Our findings regarding LAM5γ2 expression are par-
tially at variance with those recently described by Lappi-
Bianco et al [37], who observed LAM5γ2 expression in
regenerating epithelial cells in both COP and IPF/UIP, but
did not note the characteristic immunoreactivity in basal
cells at FF. In our study, the bronchiolar nature of epithe-
lial cells overlying FF was assessed by sensitive and specific
immunophenotyping using recently-introduced robust
markers such as ∆N-p63, that were not used in the afore-
mentioned study, thus possibly explaining this apparent
discrepancy.
Fascin is a 55 kD protein that binds actin, organising it
into well ordered bundles thus contributing to the forma-
tion of the various cell protrusions (filopodia, spikes,
lamellipodial ribs and dendrites) necessary for cell adhe-
sion and motility [21,38]. Fascin is not normally
expressed in pulmonary epithelial cells, but is up-regu-
lated in a number of carcinomas [39,40]. Interestingly,
fascin can also associate with β-catenin, utilising the same
binding sites used by E-cadherin and co-localising at cell-
cell borders and leading edges [20].
Heat shock protein-27 is a small molecule rapidly
induced and phosphorylated by heat shock and other
stressing agents [41]. HSP27 behaves as an actin-capping
protein interfering with its polymerisation, thus regulat-
ing cell adhesion and motility under the control of p38
MAPK (p38 mitogen-activated protein kinase) [24,25,42].
In addition, HSP27 can mediate resistance against cell
death induced by stress and differentiation [43,44]. The
mechanisms accounting for the cytoprotective functions
of HSP27 are complex, since HSP27 directly interacts with
several apoptotic effectors. Using a specific antibody, we
demonstrated that the HSP27 protein expressed at FF is
phosphorylated, arguing in favour of its biological func-
tionality.
Recent pathogenic models of IPF/UIP have been proposed,
suggesting that disturbed re-epithelialisation occurs at sites
of abnormal tissue damage and repair [3,4,7]. The demon-
stration of increased cell migration at sites of ongoing
remodelling is in line with these models, and also with the
abnormal wnt-pathway activation occurring at the same
sites as previously suggested by us (9).
Finally, according to our data, the sandwich-foci observed
in the large majority of UIP samples using LAM5γ2 and
HSP27 antibodies could represent a useful new marker for
characterisation of IPF/UIP. The UIP pattern, although
well defined in its morphological features, is not com-
pletely specific for IPF, and both mimicking and difficult
cases arise. Accordingly, full diagnostic agreement regard-
ing IPF/UIP evaluation on lung biopsy is not reached even
among expert lung pathologists [45]. The sandwich-pat-Page 8 of 10
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high quality antibodies for both LAM5γ2 and HSP27 are
available. Further studies are in progress to validate the
utility of this promising marker in the differential diagno-
sis of interstitial pneumonias on a larger series of cases.
Conclusion
The molecular abnormalities demonstrated in this study
suggest that abnormal proliferation and migration of epi-
thelial basal cells overlying myofibroblasts in FF have a
major role in the pathological remodelling characterising
IPF/UIP, leading to bronchiolar colonisation with substi-
tution of the alveolated parenchyma and eventual pro-
gression towards lung fibrosis and functional loss.
Activation of the wnt-pathway and increased expression
of proteins involved in cell migration and invasiveness are
involved in this process.
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